Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Jingjing Ye, Youwei Bi & Naitee Ting. (2023) How to select the initial dose for a pediatric study?. Journal of Biopharmaceutical Statistics 33:6, pages 844-858.
Read now
Read now
Iftekhar Mahmood. (2018) Misconceptions and issues regarding allometric scaling during the drug development process. Expert Opinion on Drug Metabolism & Toxicology 14:8, pages 843-854.
Read now
Read now
Kotaro Ogawa, Motohiro Kato, Takao Houjo & Masaki Ishigai. (2013) A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. Xenobiotica 43:5, pages 468-478.
Read now
Read now
James A. Rogers, Jayson Wilbur, Susan Cole, Paul W. Bernhardt, Jaye Lynn Bupp, Morgan J. Lennon, Nathan Langholz & Christopher Paul Steiner. (2011) Quantifying Uncertainty in Predictions of Hepatic Clearance. Statistics in Biopharmaceutical Research 3:4, pages 515-525.
Read now
Read now
Bas
J. Blaauboer. (2010) Biokinetic Modeling and in Vitro–in Vivo Extrapolations. Journal of Toxicology and Environmental Health, Part B 13:2-4, pages 242-252.
Read now
Read now
Steven E Kern. (2009) Challenges in conducting clinical trials in children: approaches for improving performance. Expert Review of Clinical Pharmacology 2:6, pages 609-617.
Read now
Read now
Thierry Lavé, Kathryn Chapman, Paul Goldsmith & Malcolm Rowland. (2009) Human clearance prediction: shifting the paradigm. Expert Opinion on Drug Metabolism & Toxicology 5:9, pages 1039-1048.
Read now
Read now
T. A. McIntyre, C. Han & C. B. Davis. (2009) Prediction of animal clearance using naïve Bayesian classification and extended connectivity fingerprints. Xenobiotica 39:7, pages 487-494.
Read now
Read now
Masoud Jamei, Steve Marciniak, Kairui Feng, Adrian Barnett, Geoffrey Tucker & Amin Rostami-Hodjegan. (2009) The Simcyp® Population-based ADME Simulator. Expert Opinion on Drug Metabolism & Toxicology 5:2, pages 211-223.
Read now
Read now
T. A. Mcintyre, C. Han, H. Xiang, R. Bambal & C. B. Davis. (2008) Differences in the total body clearance of lead compounds in the rat and mouse: Impact on pharmacokinetic screening strategy. Xenobiotica 38:6, pages 605-619.
Read now
Read now
Olavi Pelkonen, Jaime Kapitulnik, Ursula Gundert-Remy, AlanR. Boobis & Armel Stockis. (2008) Local Kinetics and Dynamics of Xenobiotics. Critical Reviews in Toxicology 38:8, pages 697-720.
Read now
Read now
. (2008) Abstracts from the 10th European Regional ISSX Meeting. Drug Metabolism Reviews 40:sup1, pages 1-172.
Read now
Read now
Stefan S De Buck & Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 865-878.
Read now
Read now
H. J. Einolf. (2007) Comparison of different approaches to predict metabolic drug–drug interactions. Xenobiotica 37:10-11, pages 1257-1294.
Read now
Read now
P. J. Lowe, Y. Hijazi, O. Luttringer, H. Yin, R. Sarangapani & D. Howard. (2007) On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development. Xenobiotica 37:10-11, pages 1331-1354.
Read now
Read now
O. Pelkonen & M. Turpeinen. (2007) extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations. Xenobiotica 37:10-11, pages 1066-1089.
Read now
Read now
Articles from other publishers (58)
Cindy H. T. Yeung, Julie Autmizguine, Pooja Dalvi, Audrey Denoncourt, Shinya Ito, Pamela Katz, Mehzabin Rahman, Yves Theoret & Andrea N. Edginton. (2024) Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions. Clinical Pharmacokinetics 63:3, pages 317-332.
Crossref
Crossref
Shivam Otavi, Tanisha Gupta, Muktika Tekade, Amrita Singh, Pinaki Sengupta, Ashish Agrawal & Rakesh Kumar Tekade. 2024. Public Health and Toxicology Issues Drug Research, Volume 2. Public Health and Toxicology Issues Drug Research, Volume 2
473
491
.
Jim Vrbanac & Ric Slauter. 2024. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
49
82
.
Dimosthenis A. Sarigiannis, Antonios K. Stratidakis & Spyridon P. Karakitsios. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
159
169
.
Nenad Manevski, Kenichi Umehara & Neil Parrott. (2023)
Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
p
) from Hepatocyte Intrinsic Clearance (CL
int
)
. Molecular Pharmaceutics 20:7, pages 3438-3459.
Crossref
Crossref
Hiroaki Iwata. (2023) Application of <i>in Silico</i> Technologies for Drug Target Discovery and Pharmacokinetic Analysis. Chemical and Pharmaceutical Bulletin 71:6, pages 398-405.
Crossref
Crossref
Zarrin Basharat, Kanwal Khan, Khurshid Jalal, Sulaiman Mohammed Alnasser, Sania Majeed & Marium Zehra. (2022) Inferring Therapeutic Targets in Candida albicans and Possible Inhibition through Natural Products: A Binding and Physiological Based Pharmacokinetics Snapshot. Life 12:11, pages 1743.
Crossref
Crossref
Hiroaki Iwata, Tatsuru Matsuo, Hideaki Mamada, Takahisa Motomura, Mayumi Matsushita, Takeshi Fujiwara, Kazuya Maeda & Koichi Handa. (2022) Predicting Total Drug Clearance and Volumes of Distribution Using the Machine Learning-Mediated Multimodal Method through the Imputation of Various Nonclinical Data. Journal of Chemical Information and Modeling 62:17, pages 4057-4065.
Crossref
Crossref
Youwei Bi, Jiang Liu, Fang Li, Jingyu Yu, Atul Bhattaram, Michael Bewernitz, Ruo‐jing Li, Jihye Ahn, Justin Earp, Lian Ma, Luning Zhuang, Yuching Yang, Xinyuan Zhang, Hao Zhu & Yaning Wang. (2021) Model‐Informed Drug Development in Pediatric Dose Selection. The Journal of Clinical Pharmacology 61:S1.
Crossref
Crossref
Hiroaki Iwata, Tatsuru Matsuo, Hideaki Mamada, Takahisa Motomura, Mayumi Matsushita, Takeshi Fujiwara, Maeda Kazuya & Koichi Handa. (2021) Prediction of Total Drug Clearance in Humans Using Animal Data: Proposal of a Multimodal Learning Method Based on Deep Learning. Journal of Pharmaceutical Sciences 110:4, pages 1834-1841.
Crossref
Crossref
Nyasha Nicole Kapungu, Xueqing Li, Charles Nhachi, Collen Masimirembwa & Roslyn Stella Thelingwani. (2020) In vitro and in vivo human metabolism and pharmacokinetics of S‐ and R‐praziquantel. Pharmacology Research & Perspectives 8:4.
Crossref
Crossref
Yohei Kosugi & Natalie Hosea. (2020) Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay. Molecular Pharmaceutics 17:7, pages 2299-2309.
Crossref
Crossref
Go-Wun Choi, Yong-Bok Lee & Hea-Young Cho. (2019) Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. Pharmaceutics 11:4, pages 168.
Crossref
Crossref
Peng Duan, Fang Wu, Jason N. Moore, Jeffrey Fisher, Victor Crentsil, Daniel Gonzalez, Lei Zhang, Gilbert J. Burckart & Jian Wang. (2018)
Assessing
CYP
2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus Inhibition
. CPT: Pharmacometrics & Systems Pharmacology 8:3, pages 158-166.
Crossref
Crossref
Neha Maharao, Jurgen Venitz & Phillip M. Gerk. (2019) Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability. Biopharmaceutics & Drug Disposition 40:1, pages 18-31.
Crossref
Crossref
Rachelle Prantil-BaunRichard NovakDebarun Das, Mahadevabharath R. Somayaji, Andrzej Przekwas & Donald E. Ingber. (2018) Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips. Annual Review of Pharmacology and Toxicology 58:1, pages 37-64.
Crossref
Crossref
F.P. Guengerich. 2018. Comprehensive Toxicology. Comprehensive Toxicology
54
86
.
Robert G. Pearce, R. Woodrow Setzer, Jimena L. Davis & John F. Wambaugh. (2017) Evaluation and calibration of high-throughput predictions of chemical distribution to tissues. Journal of Pharmacokinetics and Pharmacodynamics 44:6, pages 549-565.
Crossref
Crossref
J. Vrbanac & R. Slauter. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
39
67
.
James P. Sluka, Xiao Fu, Maciej Swat, Julio M. Belmonte, Alin Cosmanescu, Sherry G. Clendenon, John F. Wambaugh & James A. Glazier. (2016) A Liver-Centric Multiscale Modeling Framework for Xenobiotics. PLOS ONE 11:9, pages e0162428.
Crossref
Crossref
Weirong Wang & Thomayant Prueksaritanont. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
11
.
Baolian Wang, Zhihao Liu, Dan Li, Shuang Yang, Jinping Hu, Hui Chen, Li Sheng & Yan Li. (2015) Application of physiologically based pharmacokinetic modeling in the prediction of pharmacokinetics of bicyclol controlled-release formulation in human. European Journal of Pharmaceutical Sciences 77, pages 265-272.
Crossref
Crossref
Kevin McNally, Richard Cotton, Alex Hogg & George Loizou. (2015) Reprint of PopGen: A virtual human population generator. Toxicology 332, pages 77-93.
Crossref
Crossref
F. Peter Guengerich. 2015. Cytochrome P450. Cytochrome P450
523
785
.
Franco Lombardo, R. Scott Obach, Manthena V. Varma, Rowan Stringer & Giuliano Berellini. (2014) Clearance Mechanism Assignment and Total Clearance Prediction in Human Based upon in Silico Models. Journal of Medicinal Chemistry 57:10, pages 4397-4405.
Crossref
Crossref
Kevin McNally, Richard Cotton, Alex Hogg & George Loizou. (2014) PopGen: A virtual human population generator. Toxicology 315, pages 70-85.
Crossref
Crossref
S. Ho, A.S. Darwich, M. Jamei & A. Rostami–Hodjegan. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
87
94
.
HM Jones & K Rowland‐Yeo. (2013) Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development. CPT: Pharmacometrics & Systems Pharmacology 2:8, pages 1-12.
Crossref
Crossref
Hannah M. Jones, Kapil Mayawala & Patrick Poulin. (2012) Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches. The AAPS Journal 15:2, pages 377-387.
Crossref
Crossref
Hiroyuki Sayama, Hiroshi Komura & Motohiro Kogayu. (2013) Application of Hybrid Approach Based on Empirical and Physiological Concept for Predicting Pharmacokinetics in Humans—Usefulness of Exponent on Prospective Evaluation of Predictability. Drug Metabolism and Disposition 41:2, pages 498-507.
Crossref
Crossref
Jim Vrbanac & Richard Slauter. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
3
30
.
Yanguang Cao & William J. Jusko. (2012) Applications of minimal physiologically-based pharmacokinetic models. Journal of Pharmacokinetics and Pharmacodynamics 39:6, pages 711-723.
Crossref
Crossref
Alexander V. LyubimovHiroshi Komura & Masahiro Iwaki. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
41
.
Giuliano Berellini, Nigel J. Waters & Franco Lombardo. (2012) In silico Prediction of Total Human Plasma Clearance. Journal of Chemical Information and Modeling 52:8, pages 2069-2078.
Crossref
Crossref
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
209
227
.
Kevin Beaumont, Iain Gardner, Kathryn Chapman, Michael Hall & Malcolm Rowland. (2011) Toward an integrated human clearance prediction strategy that minimizes animal use. Journal of Pharmaceutical Sciences 100:10, pages 4518-4535.
Crossref
Crossref
Shinji Yamazaki, Judith Skaptason, David Romero, Sylvia Vekich, Hannah M. Jones, Weiwei Tan, Keith D. Wilner & Tatiana Koudriakova. (2011) Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model. Drug Metabolism and Disposition 39:3, pages 383-393.
Crossref
Crossref
Andrea N. Edginton. (2010) Knowledge‐driven approaches for the guidance of first‐in‐children dosing. Pediatric Anesthesia 21:3, pages 206-213.
Crossref
Crossref
Sekihiro Tamaki, Hiroshi Komura, Motohiro Kogayu & Shizuo Yamada. (2011) Comparative Assessment of Empirical and Physiological Approaches on Predicting Human Clearances. Journal of Pharmaceutical Sciences 100:3, pages 1147-1155.
Crossref
Crossref
Feras Khalil & Stephanie Läer. (2011) Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development. Journal of Biomedicine and Biotechnology 2011, pages 1-13.
Crossref
Crossref
Tobias Pähler & Jochen Maas. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
9
13
.
Daniel M. Rotroff, Barbara A. Wetmore, David J. Dix, Stephen S. Ferguson, Harvey J. Clewell, Keith A. Houck, Edward L. LeCluyse, Melvin E. Andersen, Richard S. Judson, Cornelia M. Smith, Mark A. Sochaski, Robert J. Kavlock, Frank Boellmann, Matthew T. Martin, David M. Reif, John F. Wambaugh & Russell S. Thomas. (2010)
Incorporating Human Dosimetry and Exposure into High-Throughput
In Vitro
Toxicity Screening
. Toxicological Sciences 117:2, pages 348-358.
Crossref
Crossref
Zvi Teitelbaum, Thierry Lave, Jan Freijer & Adam F. Cohen. (2010) Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans. Clinical Pharmacokinetics 49:9, pages 619-632.
Crossref
Crossref
Melvin J. Yu. (2010) Predicting Total Clearance in Humans from Chemical Structure. Journal of Chemical Information and Modeling 50:7, pages 1284-1295.
Crossref
Crossref
Olavi Pelkonen, Ari Tolonen, Miia Turpeinen & Jouko Uusitalo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
32
.
F.P. Guengerich. 2010. Comprehensive Toxicology. Comprehensive Toxicology
41
76
.
Tonika Bohnert & Liang‐Shang Gan. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
91
176
.
Stuart Creton, Richard Billington, Will Davies, Matthew P. Dent, Gabrielle M. Hawksworth, Simon Parry & Kim Z. Travis. (2009) Application of toxicokinetics to improve chemical risk assessment: Implications for the use of animals. Regulatory Toxicology and Pharmacology 55:3, pages 291-299.
Crossref
Crossref
Kenji Tabata, Nozomu Hamakawa, Seigo Sanoh, Shigeyuki Terashita & Toshio Teramura. (2009) Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research. European Journal of Drug Metabolism and Pharmacokinetics 34:2, pages 117-128.
Crossref
Crossref
N. Parrott, V. Lukacova, G. Fraczkiewicz & M. B. Bolger. (2009) Predicting Pharmacokinetics of Drugs Using Physiologically Based Modeling—Application to Food Effects. The AAPS Journal 11:1, pages 45-53.
Crossref
Crossref
Hye Young Ji, Beom Soo Shin, Dong Won Jeong, Eun Jeong Park, Eun-Seok Park, Sun Dong Yoo & Hye Suk Lee. (2009) Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Archives of Pharmacal Research 32:2, pages 251-257.
Crossref
Crossref
Hirotaka Ando, Shigeru Izawa, Wataru Hori & Ippei Nakagawa. (2008) Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling. Theoretical Biology and Medical Modelling 5:1.
Crossref
Crossref
Aberra Fura, Viral Vyas, William Humphreys, Anjaneya Chimalokonda & David Rodrigues. (2008) Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Biopharmaceutics & Drug Disposition 29:8, pages 455-468.
Crossref
Crossref
Kuresh A. Youdim, Aref Zayed, Maurice Dickins, Alex Phipps, Michelle Griffiths, Amanda Darekar, Ruth Hyland, Odette Fahmi, Susan Hurst, David R. Plowchalk, Jack Cook, Feng Guo & R. Scott Obach. (2008)
Application of CYP3A4
in vitro
data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction
. British Journal of Clinical Pharmacology 65:5, pages 680-692.
Crossref
Crossref
Christine Huang, Ming Zheng, Zheng Yang, A. David Rodrigues & Punit Marathe. (2007) Projection of Exposure and Efficacious Dose Prior to First-in-Human Studies: How Successful Have We Been?. Pharmaceutical Research 25:4, pages 713-726.
Crossref
Crossref
Stefan S. De Buck, Vikash K. Sinha, Luca A. Fenu, Ron A. Gilissen, Claire E. Mackie & Marjoleen J. Nijsen. (2007) The Prediction of Drug Metabolism, Tissue Distribution, and Bioavailability of 50 Structurally Diverse Compounds in Rat Using Mechanism-Based Absorption, Distribution, and Metabolism Prediction Tools. Drug Metabolism and Disposition 35:4, pages 649-659.
Crossref
Crossref
Jeffrey S. Barrett. (2007) Facilitating Compound Progression of Antiretroviral Agents via Modeling and Simulation. Journal of Neuroimmune Pharmacology 2:1, pages 58-71.
Crossref
Crossref
Amin Rostami-Hodjegan & Geoffrey T. Tucker. (2007) Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nature Reviews Drug Discovery 6:2, pages 140-148.
Crossref
Crossref